Epigenetics Market About To Generate Revenue Worth 890.0 Million USD by 2020

The report "Epigenetics Market by Product (Modifying Enzymes, DNA Polymerase, Acetylase, Methyltransferase, Instruments & Consumables, Kit, Bisulphite Conversion Kit, Reagents), by Research Area (Developmental Biology, Oncology) - Global Forecast to 2020", The epigenetics market is expected to reach USD 890.0 Million by 2020 from USD 469.6 Million in 2015, at a CAGR of 13.64% between 2015 and 2020.

Persone Rohan Unit
Luoghi America del Nord, India, Pune, Stati Uniti d'America, Maharashtra, Wé
Organizzazioni Zymo Research Corporation, Thermo Fisher Scientific Inc., Sigma-Aldrich Corporation, New England Biolabs Inc., Merck & Co., N.V., QIAGEN, Epigenetics Market, Instruments & Consumables, Unione Socialista Indipendente
Argomenti commercio, economia, impresa

19/feb/2016 09.28.39 MarketsandMarkets Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.
The report "Epigenetics Market by Product (Modifying Enzymes, DNA Polymerase, Acetylase, Methyltransferase, Instruments & Consumables, Kit, Bisulphite Conversion Kit, Reagents), by Research Area (Developmental Biology, Oncology) - Global Forecast to 2020", The epigenetics market is expected to reach USD 890.0 Million by 2020 from USD 469.6 Million in 2015, at a CAGR of 13.64% between 2015 and 2020.
 
Browse 84 market tables and 82 figures spread through 158 pages and in-depth TOC on "Epigenetics Market"
http://www.marketsandmarkets.com/Market-Reports/epigenetics-technologies-market-896.html
Early buyers will receive 10% customization on this report.
 
The increasing prevalence of cancer and increased funding for epigenetics research, along with growing partnerships between biotechnology and pharmaceutical companies for the development of epigenetics-based products will be the most important growth drivers for this market in the forecast period from 2014 to 2019.
 
The global epigenetics market is segmented into product segments of enzymes, instruments & consumables, kits, and reagents. The enzymes product segment is further sub segmented into DNA-modifying enzymes (DNA ligases, DNA polymerases and other DNA-modifying enzymes); protein-modifying enzymes (acetylases, methyltransferases and other protein-modifying enzymes); and RNA-modifying enzymes (reverse transcriptases, RNA ligases, and other RNA-modifying enzymes).
 
Speak To Our Research Analysts: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=896
 
The instruments & consumables product segment is further sub segmented into mass spectrometers; next-generation sequencers; qPCRs; sonicators; and other epigenetics instruments & consumables. The kits product segment is further sub segmented into bisulfite conversion kits; ChIP-seq kits; RNA sequencing kits; whole genome amplification kits; 5-hmC & 5-mC analysis kits; and other epigenetics kits. The reagents product segment is further sub segmented into antibodies; buffers; histones; magnetic beads; primers; and other epigenetics reagents.
 
The research areas included in this report are developmental biology; drug discovery; oncology; and other epigenetics research areas. The oncology segment had the largest share of the epigenetics market in 2014, owing to the increased prevalence of cancer. On the basis of end users, the global epigenetics market report is segmented into academic research institutes, biotechnology and pharmaceutical companies, and contract research organizations. Academic research institutes were the largest end-user segment of this market in 2014.
 
Geographic analysis revealed that North America accounted for the largest share of the global epigenetics market in 2014. The Asian regional segment, on the other hand, is expected to register double-digit growth from 2014 to 2019, due to the increased R&D funding in this region.
 
You can also get this report customized: http://www.marketsandmarkets.com/requestCustomization.asp?id=896
 
Major players in the global epigenetics market are Abcam plc. (U.K), Illumina, Inc. (U.S.), QIAGEN N.V. (Netherland), Merck & Co. (U.S.), New England Biolabs, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), Thermo Fisher Scientific, Inc., (U.S.), Active Motif (U.S.), Diagenode, Inc. (Belgium) and Zymo Research Corporation (U.S.).
 
About MarketsandMarkets:
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
 
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
 
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
 
Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Subscription.html
 
Contact:
Mr. Rohan

Unit No. 802, 8th Floor, 
Tower - 7, Magarpatta City SEZ,
Hadapsar, Pune – 411013, 
Maharashtra, India.
Tel: +1-888-6006-441.
Get your own FREE website, FREE domain & FREE mobile app with Company email.  
Know More >
blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl